GLAND PHARMA
Back to Cashflow Statement
|
GLAND PHARMA Last 5 Year Net Cash Inflow / Outflow History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Net Cash Inflow / Outflow | ₹2,186 Cr | ₹-1,560 Cr | ₹1,587 Cr | ₹-177 Cr | ₹319 Cr |
What is the latest Net Cash Inflow / Outflow ratio of GLAND PHARMA ?
| Year | Net Cash Inflow / Outflow |
|---|---|
| Mar2025 | ₹2,186 Cr |
| Mar2024 | ₹-1,560 Cr |
| Mar2023 | ₹1,587 Cr |
| Mar2022 | ₹-177 Cr |
| Mar2021 | ₹319 Cr |
How is Net Cash Inflow / Outflow of GLAND PHARMA Trending?
| Years | Net Cash Inflow / Outflow | % Change | |
|---|---|---|---|
| Mar2025 | ₹2,186 Cr | Positive | |
| Mar2024 | ₹-1,560 Cr | Negative | |
| Mar2023 | ₹1,587 Cr | Positive | |
| Mar2022 | ₹-177 Cr | Negative | |
| Mar2021 | ₹319 Cr | - | |
Compare Net Cash Inflow / Outflow of peers of GLAND PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| GLAND PHARMA | ₹41,038.0 Cr | -3.6% | 6.7% | 32.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹465,507.0 Cr | 1.1% | 7.2% | 15.4% | Stock Analytics | |
| DIVIS LABORATORIES | ₹190,744.0 Cr | 2.4% | 4.2% | -1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹168,250.0 Cr | 1.9% | 8.3% | 45.6% | Stock Analytics | |
| CIPLA | ₹116,213.0 Cr | -1.8% | 3.2% | -4.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹103,980.0 Cr | -8.8% | -3.2% | -4.6% | Stock Analytics | |
GLAND PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| GLAND PHARMA | -3.6% |
6.7% |
32.3% |
| SENSEX | -1.4% |
4.4% |
-7.6% |
You may also like the below Video Courses